London, United Kingdom-based bladder health startup Jude raised EUR 3.9 million in funding. The company announced the investment on September 4, 2023. Eka Ventures and Joyance led the financing for the company. Meanwhile, the round also saw follow-on investment from June Angelides at Samos VC. The investment also includes Dr Fiona Pathiraja of Crista Galli Ventures, as well as received a grant from Innovate UK.

Purpose of financing for Jude

With the latest financing, Jude seeks to target the US market. It also seeks expansion of its services to support healthy ageing and improved bladder health from symptoms to solution, with access to healthcare services, supplements and medication.

With the additional funds, Jude has plans to launch into the American market. It intends to achieve this via retail at the end of the year and via direct-to-consumer at the beginning of 2024.

In addition, the company plans to further expand its range of products and services to launch symptom-tracking prescriptions and advance research into the underserved area of nutrition and urinary health.

What the company’s official has to add

Peony Li, the founder of the company, stated, “We know women’s health suffers from chronic underfunding and a lack of research. There’s little medication and not enough training for healthcare professionals in bladder health specifically. We want to make the entire journey – from symptom to solution – better for people with poor bladder health. This investment will be critical in us achieving this mission and expanding our services to the US, where 75 million people struggle with these issues. I’m incredibly happy to welcome Eka Ventures and Joyance and to continue our partnership with Samos VC.”

What the investors have to add

Camilla Dolan, Eka Ventures, further added, “We have been consistently impressed with Peony’s vision and the deep appreciation she has for building out a brand underpinned by a strong and supportive community and understanding the needs of the consumer. The size of the commercial opportunity is enormous. There is currently no scaled player that provides a holistic solution to prevention, treatment and management of incontinence and prostate-related issues or a scaled player focused on healthy ageing.” 

About Jude

Peony Li is the founder of the company launched in 2022. Jude serves 16,000 customers. It further launched innovative market products such as a new natural treatment for lower urinary tract issues that reduces incontinence, being prescribed by doctors to patients across Europe and a support hotline. The company works with Southampton University Hospital, West Suffolk NHS Trust, and London Menopause Clinic. Jude has plans to deliver a holistic treatment based on a personalised consultation right to customers’ doorstep.

For more extensive analysis and Market Intelligence reports, feel free to approach us.

We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know

if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover

–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!

Next Article

Previous articleInnovac Therapeutics raises USD 18 million in pre-Series A financing 
Next articleIreland-based Mail Metrics acquires Dafil
Jasleen Bhatia works as a content writer for VCBay News. She is pursuing her final semester in Bachelor of Business Administration from IIPS, DAVV. Driven by her keen interest in entrepreneurship and finance, she writes business-related articles.

LEAVE A REPLY

Please enter your comment!
Please enter your name here